Director, Chairman & CEO · GILEAD SCIENCES, INC. · GILEAD SCIENCES, INC. — Non-qualified Stock Option (Right to Buy)
Side
M
Value
—
Shares
102.6K
Price
—
Executed
Nov 4, 2026
Disclosed
Nov 6, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 4 executedNov 6, 2026 disclosed
GILD · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 289.1% of prior position
Filing timing0 / 15
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
4 prior trades recorded in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
Pre-arranged plan-10
Executed under a Rule 10b5-1 trading plan
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
GILEAD SCIENCES, INC. — Non-qualified Stock Option (Right to Buy)
Ticker
GILD
Shares
102.6K
Price per share
$0
Execution date (reported)
Nov 4, 2026
Owned after transaction
138.1K shares
Rule 10b5-1 plan
Yes, as checked by the filer
Days from execution to publication
2
What this establishes
O'Day Daniel Patrick filed this Form 4 reporting a option exercise of GILD on Nov 4, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, Chairman & CEO
O'Day Daniel Patrickcik:0001638643
Issuer
GILEAD SCIENCES, INC.cik:0000882095
Revision history · 0
No field has changed since this record was first ingested.
